Moderna (NASDAQ: MRNA) has proved itself when it comes to handling the original coronavirus and the variants that have emerged since the beginning of the year. The biotech company's vaccine has offered protection across the board. In fact, some real-world studies have even shown Moderna's vaccine to be more efficacious than those of its rivals.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting